Antagonists of melanin concentrating hormone receptor
申请人:Millennium Pharmaceuticals, Inc.
公开号:US20040106645A1
公开(公告)日:2004-06-03
This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1). The compounds are represented by formula I:
1
where m is zero or one, n is zero to two, Y is oxygen or —N(R
9
)—, R
1
, R
2
, R
3
, R
4
, R
5
, R
9
and Ring A are defined in the specification. Coumarin and quinolone compounds where R
1
and R
2
together form a fused benzo ring are preferred. The invention also provides compounds of formula VI where the coumarin moiety is replaced by a quinazolinone ring. The compounds are useful for treating MCH-R1-related disorders, particularly overweight conditions including obesity.
这项发明提供了一些与黑色素浓集激素受体-1 (MCH-R1) 相对抗的化合物。这些化合物由公式 I 表示:其中 m 为零或一,n 为零至二,Y 为氧或 —N(R9)—,R1、R2、R3、R4、R5、R9 和环 A 在说明书中有定义。偏好使用 R1 和 R2 结合形成融合苯环的香豆素和喹啉类化合物。该发明还提供了公式 VI 的化合物,其中香豆素基团被喹嗪酮环替换。这些化合物可用于治疗与 MCH-R1 相关的疾病,特别是超重症,包括肥胖症。
ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR
申请人:ABBOTT LABORATORIES
公开号:EP1534703A2
公开(公告)日:2005-06-01
US6921821B2
申请人:——
公开号:US6921821B2
公开(公告)日:2005-07-26
[EN] ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR<br/>[FR] ANTAGONISTES DU RECEPTEUR DE L'HORMONE DE MELANO-CONCENTRATION